Promising tacrine/huperzine A‐based dimeric acetylcholinesterase inhibitors for neurodegenerative disorders: From relieving symptoms to modifying diseases through multitarget-Reference-Cited by-同舟云学术

Promising tacrine/huperzine A‐based dimeric acetylcholinesterase inhibitors for neurodegenerative disorders: From relieving symptoms to modifying diseases through multitarget

Published:2021-07-05 Issue:6 Volume:158 Page:1381-1393
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:J. Neurochem.

Author:

Mak Shinghung¹²^ORCID,Li Wenming³,Fu Hongjun⁴,Luo Jialie⁵,Cui Wei⁶,Hu Shengquan⁷,Pang Yuanping⁸,Carlier Paul R.⁹,Tsim Karl Wahkeung¹²,Pi Rongbiao¹⁰,Han Yifan¹¹^ORCID

Affiliation:

1. Shenzhen Key Laboratory of Edible and Medicinal Bioresources HKUST Shenzhen Research Institute Shenzhen China

2. Division of Life Science and Center for Chinese Medicine and State Key Laboratory of Molecular Neuroscience The Hong Kong University of Science and Technology Hong Kong China

3. Department of Pharmacology and Chemical Biology Emory University School of Medicine Atlanta GA USA

4. Department of Neuroscience Chronic Brain Injury The Ohio State University Columbus OH USA

5. Department of Anesthesiology The Center for the Study of Itch and Sensory Disorders Washington University School of Medicine St. Louis MO USA

6. Zhejiang Provincial Key Laboratory of Pathophysiology Ningbo Key Laboratory of Behavioral Neuroscience School of Medicine Ningbo University Ningbo China

7. Shenzhen Institute of Geriatrics Shenzhen Second People's Hospital The First Affiliated Hospital of Shenzhen University Shenzhen China

8. Mayo Cancer Center Department of Pharmacology Mayo Clinic Rochester MN USA

9. Department of Chemistry Virginia Tech Blacksburg VA USA

10. Department of Pharmacology School of Medicine Sun Yat‐sen University Guangzhou China

11. Department of Applied Biology and Chemical Technology Institute of Modern Medicine The Hong Kong Polytechnic University Hong Kong China

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jnc.15379

Reference131 articles.

1. Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions

2. Bapineuzumab for mild to moderate Alzheimer’s disease: a meta-analysis of randomized controlled trials

3. Postnatal Loss of Mef2c Results in Dissociation of Effects on Synapse Number and Learning and Memory

4. 2016 Alzheimer's disease facts and figures

5. Multi-Target-Directed Ligands in Alzheimer's Disease Treatment

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suppressing ERp57 diminishes osteoclast activity and ameliorates ovariectomy-induced bone loss via the intervention in calcium oscillation and the calmodulin/calcineurin/Nfatc1 pathway;Heliyon;2024-08

2. Current Insights of Nanocarrier-Mediated Gene Therapeutics to Treat Potential Impairment of Amyloid Beta Protein and Tau Protein in Alzheimer’s Disease;Molecular Neurobiology;2023-10-13

3. Pathways to healing: Plants with therapeutic potential for neurodegenerative diseases;IBRO Neuroscience Reports;2023-06

4. Acridine: A Scaffold for the Development of Drugs for Alzheimer's Disease;Current Topics in Medicinal Chemistry;2023-05

5. The Role of MEF2 Transcription Factor Family in Neuronal Survival and Degeneration;International Journal of Molecular Sciences;2023-02-04